Exploring the Theoretical Potential of Benzphetamine in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

Benzphetamine HCl (Didrex) is a Schedule III amphetamine indicated for the treatment of obesity. Amphetamine and methylphenidate are CNS stimulants regarded as the most effective treatment for attention-deficit/hyperactivity disorder (ADHD). Currently, both classes comprise the nationwide shortage of stimulants used to treat ADHD. Benzphetamine is a prodrug yielding dextroamphetamine (Zenzedi) and dextromethamphetamine (formerly Desoxyn). Both metabolites hold FDA approval to treat ADHD,…

via https://pubmed.ncbi.nlm.nih.gov/41476437/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20260116010905&v=2.18.0.post22+67771e2